Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study.  Olafsson S, Love TJ, Fridriksdottir RH, Tyrfingsson T, Runarsdottir V, H…

Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain.  Ryan P, Valencia J, Sepúlveda-Crespo D, Amigot-Sánchez R, Cuevas G, Lazarus JV, Pérez-García F, Martínez I, Resino S.  JAMA Netw Open. 2024 Oct 1;7(10)…

Hepatitis C Virus Infection in Europe.  Simão M, Gonçalves C.  Pathogens. 2024 Sep 28;13(10):841. doi: 10.3390/pathogens13100841. PMID: 39452713; PMCID: PMC11510056. https://pmc.ncbi.nlm.nih.gov/articles/PMC11510056/  

Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey.  Maher L, Wand H, Heard S, Starr M, Zolala F…

Feasibility and Performance of a Point-of-Care Hepatitis C RNA Assay in a Community Supervision Cohort.  Harvey L, Jacka B, Bazerman L, et al.  JAMA Netw Open. 2024;7(10):e2438222. doi:10.1001/jamanetworkopen.2024.38222 https://jam…

More than Just Buying a Van: Lessons Learned from a Mobile Telehealth HCV Testing and Treatment Study.  Bianchet E, de Gijsel D, Del Toro-Mejias LM, Stopka TJ, Hoskinson RA Jr, Dowd P, Friedmann PD.  Viruses. 2024 Aug 30;16(9):1388. doi…